GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Darya-Varia Laboratoria Tbk (ISX:DVLA) » Definitions » Owner Earnings per Share (TTM)

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Owner Earnings per Share (TTM) : 100.13 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is PT Darya-Varia Laboratoria Tbk Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM) ended in Mar. 2024 was Rp100.13. It's Price-to-Owner-Earnings ratio for today is 15.83.


The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM) or its related term are showing as below:

ISX:DVLA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.12   Med: 18.79   Max: 125.57
Current: 15.38


During the past 13 years, the highest Price-to-Owner-Earnings ratio of PT Darya-Varia Laboratoria Tbk was 125.57. The lowest was 10.12. And the median was 18.79.


ISX:DVLA's Price-to-Owner-Earnings is ranked better than
72.07% of 426 companies
in the Drug Manufacturers industry
Industry Median: 24.73 vs ISX:DVLA: 15.38

PT Darya-Varia Laboratoria Tbk's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was Rp60.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was Rp136.14. It's PE Ratio ratio for today is 11.64.

PT Darya-Varia Laboratoria Tbk's EPS without NRI for the three months ended in Mar. 2024 was Rp59.53. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was Rp133.61. It's PE Ratio without NRI ratio for today is 11.86.


PT Darya-Varia Laboratoria Tbk Owner Earnings per Share (TTM) Historical Data

The historical data trend for PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Darya-Varia Laboratoria Tbk Owner Earnings per Share (TTM) Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.84 107.12 116.16 111.46 98.14

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.09 41.26 44.92 98.14 100.13

Competitive Comparison of PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM)

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Darya-Varia Laboratoria Tbk's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Price-to-Owner-Earnings falls into.



PT Darya-Varia Laboratoria Tbk Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 152,911
Depreciation, Depletion and Amortization 35,926
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 76,696
Change In Working Capital 0
Shares Outstanding (Diluted Average) 1,120

1. Start with "Net Income" from income statement. PT Darya-Varia Laboratoria Tbk's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was Rp152,911 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. PT Darya-Varia Laboratoria Tbk's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Mar. 2024 was Rp35,926 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. PT Darya-Varia Laboratoria Tbk's Change In Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 was Rp0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = Rp76,696 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

PT Darya-Varia Laboratoria Tbk's 5-Year Average Maintenance Capital Expenditure = Rp76,696 Mil

5. "Change In Working Capital" is from cashflow statement. PT Darya-Varia Laboratoria Tbk's Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 was Rp0 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. PT Darya-Varia Laboratoria Tbk's Shares Outstanding (Diluted Average) for the months ended in Mar. 2024 was 1120.000 Mil.

PT Darya-Varia Laboratoria Tbk's Onwer Earnings Per Share for Mar. 2024 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 152910.592 +35926.154+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-76696.44670827+0)/1120.000
=100.13

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=1585.00/100.13
=15.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


PT Darya-Varia Laboratoria Tbk Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of PT Darya-Varia Laboratoria Tbk's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Business Description

Traded in Other Exchanges
N/A
Address
Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Headlines

No Headlines